Researchers are exploring new approaches to treat autoimmune diseases, as current lifelong drugs have limited effectiveness. Some companies, such as AstraZeneca and Kyverna, are working on therapies, including CAR-T treatments, that may offer alternative solutions. The potential for a cure for various autoimmune conditions is being investigated, with some studies also drawing parallels with cancer treatments.